Active Ingredient: SAXAGLIPTIN HYDROCHLORIDE
Proprietary Name: ONGLYZA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 2.5MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N022350
Product Number: 001
Approval Date: Jul 31, 2009
Applicant Holder Full Name: ASTRAZENECA AB
Marketing Status:
Discontinued
Patent and Exclusivity Information
